Veravas

Veravas is a laboratory diagnostic company with a patient sample transformation technology, VeraBIND (Biomarker Isolation and N-richment for Detection) dedicated to making early detection of disease related biomarkers possible in challenging sample types. Veravas’ products are designed with convenience, sensitivity, accuracy, and cost-effectiveness in mind, allowing researchers, lab directors, commercial test manufacturers, and Veravas themselves to develop highly sensitive assays for early detection of disease, clinical trials, precision diagnosis, and treatment monitoring. Veravas' VeraBIND™ technology transforms the original sample into a standardized, matrix-free sample that laboratories can analyze using existing equipment and without adding time to result. Veravas is reshaping the landscape of assay development and biomarker detection, setting a new standard in clinical diagnostics and research. Can impact immunoassay signal response and deliver false test results. The sample collection stage is the optimal point to eliminate these interferences.